Yüklüyor......

Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma

Portal vein embolization (PVE) for hepatocellular carcinoma (HCC) was first introduced in 1986 and has been continuously developed throughout the years. Basically, PVE has been applied to expand the indication of liver resection for HCC patients of insufficient future liver remnant. Importantly, PVE...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Gastroenterol Surg
Asıl Yazarlar: Beppu, Toru, Yamamura, Kensuke, Okabe, Hirohisa, Imai, Katsunori, Hayashi, Hiromitsu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164464/
https://ncbi.nlm.nih.gov/pubmed/34095718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12414
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!